Analysis of tumor specimens at the time of acquired resistance to EGFR-TKI therapy in 155 patients with EGFR-mutant lung cancers.

Yu HA, Arcila ME, Rekhtman N, Sima CS, Zakowski MF, Pao W, Kris MG, Miller VA, Ladanyi M, Riely GJ
Clin Cancer Res. 2013 19 (8): 2240-7

PMID: 23470965 · PMCID: PMC3630270 · DOI:10.1158/1078-0432.CCR-12-2246

MeSH Terms (26)

Adenocarcinoma Adult Aged Aged, 80 and over Biopsy CD56 Antigen DNA Mutational Analysis Drug Resistance, Neoplasm ErbB Receptors Erlotinib Hydrochloride Female Gefitinib Humans Immunohistochemistry In Situ Hybridization, Fluorescence Kaplan-Meier Estimate Ki-67 Antigen Lung Lung Neoplasms Male Middle Aged Mutation Protein Kinase Inhibitors Proto-Oncogene Proteins c-met Quinazolines Receptor, ErbB-2

Connections (2)

This publication is referenced by other Labnodes entities: